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Background: Toll-like receptor 3 (TLR3) is expressed in upper airways, however, little is known regarding
whether Toll-like receptor 3 (TLR3) signals exert a regulatory effect on the pathogenesis of chronic
rhinosinusitis with nasal polyps (CRSwNP), especially on eosinophilic inﬂammation. We sought to
investigate the effect of Poly(IC), the ligand for TLR3, on cytokine production by dispersed nasal polyp
cells (DNPCs).
Methods: DNPCs were pretreated with or without Poly(IC), and were then cultured in the presence or
absence of staphylococcal enterotoxin B (SEB), following which the levels of IL-5, IL-10, IL-13, IL-17A and
interferon (IFN)-g in the supernatant were measured. To determine the involvement of IL-10 and
cyclooxygenase in Poly(IC)-mediated signaling, DNPCs were treated with anti-IL-10 monoclonal antibody
and diclofenac, the cyclooxygenase inhibitor, respectively. Poly(IC)-induced prostaglandin E2 (PGE2)
production was also determined.
Results: Exposure to Poly(IC) induced a signiﬁcant production of IL-10, but not of IL-5, IL-13, IL-17A or
IFN-g by DNPCs. Pretreatment with Poly(IC) dose-dependently inhibited SEB-induced IL-5, IL-13 and IL-
17A, but not IFN-g production. Neutralization of IL-10 signiﬁcantly abrogated the inhibitory effect of
Poly(IC). Treatment with diclofenac also abrogated the inhibitory effect of Poly(IC) on SEB-induced IL-5
and IL-13 production. However, unlike exposure of diclofenac-treated DNPCs to lipopolysaccharide, the
ligand for TLR4, exposure of these cells to Poly(IC) did not enhance IL-5 or IL-13 production. Poly(IC) did
not signiﬁcantly increase PGE2 production by DNPCs.
Conclusions: These results suggest that TLR3 signaling regulates eosinophilia-associated cytokine pro-
duction in CRSwNP, at least in part, via IL-10 production.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Toll-like receptors (TLRs) are the major elements of innate im-
munity, and TLR-mediated signals are known to be associated with





rgology. Production and hosting by Else(CRSwNP).1e3 For example, nasal polyp ﬁbroblasts produce
macrophage inﬂammatory protein-3alpha (MIP-3alpha) in
response to TLR ligands.4 On the other hand, signals mediated
through TLRs have been shown to regulate airway inﬂammation in
a manner that may reﬂect the concept of the “hygiene (in other
words microbial) hypothesis” in which early exposure to microbial
stimuli prevents later chronic inﬂammatory conditions.5e8 For
example, exposure to CpG oligodeoxynucleotide, the ligand for
TLR9, reduces the production of IL-6, G-CSF and MIP-1b by turbi-
nate tissue from patients with CRSwNP.6 We have recently
demonstrated that pre-exposure of dispersed nasal polyp cellsvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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presses staphylococcal enterotoxin B (SEB)-induced IL-5, IL-13, IFN-
g and IL-17A production via cyclooxygenase (COX) and prosta-
glandin E2 (PGE2) pathway.7
TLR3 is expressed in intracellular vesicles such as the endosome,
and recognizes viral components including dsRNA. Unlike other
TLRs, TLR3 initiates a TRIF-dependent, but MyD88-independent,
pathway for its actions.9 In upper airways, TLR3 is found on
constitutive cells including epithelial cells and ﬁbroblasts.10,11
Signaling through TLR3 induces the production of pro-
inﬂammatory cytokines and chemokines including IL-6, IL-8, GM-
CSF, TARC, RANTES, TSLP and osteopontin.10e15 However, little is
known regarding whether TLR signals exert a regulatory effect on
upper airway inﬂammation, especially on eosinophilic
inﬂammation.
In the present study, we investigated whether exposure to
polyinosinic: polycytidylic acid (Poly(IC)), the ligand for TLR3, af-
fects IL-5, IL-13, IFN-g or IL-17A production by DNPCs in response to
SEB, which is a candidate agent for facilitation of the pathogenesis
of CRSwNP.16 We found that the regulatory effect of TLR3 signaling
on SEB-induced cytokine production was mediated by a different




The study utilized nasal polyps that were surgically excised from
36 Japanese CRSwNPs patients (age range, 20e78 years; mean age,
53.5 years). The presence of CRSwNPs was determined based upon
diagnostic criteria reported in a European position paper on rhi-
nosinusitis and nasal polyps.17 According to the JESREC (Japanese
epidemiological survey of refractory eosinophilic chronic rhinosi-
nusitis) criterion, 23 NPs were eosinophilic (over 70 eosinophils
per400 ﬁeld).18 Eleven patients were asthmatic, and four patients
were thought to have aspirin exacerbated respiratory disease
(AERD) based on a history of asthma attacks precipitated by non-
steroidal anti-inﬂammatory drugs. Exclusion criteria were as
described previously.7 Informed consent for participation in the
study was obtained from each patient. The study was approved by
the Human Research Committee of the Okayama University Grad-
uate School of Medicine and Dentistry.
Antigen and reagents
The following materials were purchased for the study: Poly(IC),
RPMI-1640, L-glutamine-penicillin-streptomycin solution, prote-
ase, collagenase, hyaluronidase, DNase I, fetal calf serum (FCS)
(Sigma, St. Louis, MO, USA); red blood cell lysis buffer (Roche,
Indianapolis, IN, USA); SEB (Toxin Technology, Sarasota, FL, USA);
diclofenac sodium (Wako Pure Chemicals, Osaka, Japan); rat anti-
human IL-10 mAb (LifeSpan BioSciences, Inc., Seattle, WA, USA),
and rat IgG1 (R&D Systems, Minneapolis, MN, USA).
Culture of dispersed nasal polyp cells with Poly(IC)
Dispersed nasal polyp cells were prepared from nasal polyps by
enzymatic digestion, as described previously, and suspended in
culture medium containing RPMI-1640 supplemented with 10%
FCS, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml strepto-
mycin.7 8.5 ± 5.3%, 11.7 ± 8.9%, 8.9 ± 8.2%, 8.5 ± 6.8%, 7.8 ± 11.1%,
10.9 ± 10.5%, 15.5 ± 6.7%, and 21.6 ± 7.7% cells in DNPCs express c-
kit, ECP/EPX, CD79a, CD68, CD4, CD8, cytokeratin, and vimentin,
respectively, suggesting that DNPCs consist of both constitutivecells and inﬂammatory cells including mast cells, eosinophils, B
cells, macrophages, CD4þ T cells, CD8þ T cells, epithelial cells, and
ﬁbroblasts/vascular endothelial cells.7 These DNPCs, in a volume of
500 ml/well (1  106 DNPCs/ml) in ﬂat-bottomed 48-well culture
plates (Asahi Techno Glass, Tokyo, Japan), were stimulated with 1,
10, or 100 mg/ml of Poly(IC) and were incubated at 37 C in a 5% CO2
atmosphere. An aliquot of the culture supernatant was collected
after 12 and 72 h and was stored at 80 C for subsequent analysis
of the cytokines IL-5, IL-10, IL-13, IL-17A and IFN-g.
Effects of Poly(IC) on SEB-induced cytokine production by DNPCs
DNPCs were cultured with or without Poly(IC) at 1, 10 or 100 mg/
ml for 2 h prior to SEB stimulation (1 ng/ml). The culture super-
natant was collected after SEB stimulation for 72 h, after which the
levels of IL-5, IL-13, IL-17A and IFN-g were determined.
Role of IL-10 and COX in the regulatory effect of Poly(IC) on SEB-
induced cytokine production by DNPCs
To determine the role of IL-10 in the effect of Poly(IC) on SEB-
induced cytokine production, DNPCs were pretreated with or
without 100 mg/ml Poly(IC), and were then stimulated with SEB in
the presence of either anti-human IL-10 mAb or control rat IgG1
(20 mg/ml) for 72 h. To determine the role of cyclooxygenase (COX),
DNPCs were pretreated with 105 M diclofenac 2 h prior to Poly(IC)
treatment.
Effect of Poly(IC) on PGE2 production by DNPCs
DNPCs (1 106/ml) were cultured in the presence or absence of
100 mg/ml Poly(IC) for 12 or 72 h. The concentration of PGE2 in the
supernatant was determined using a PGE2 EIA kit (Cayman, Ann
Arbor, MI, USA). The detection limit was 7.8 pg/ml.
Cytokine determination
Levels of IL-5, IL-10, IL-13, IL-17A and IFN-g in the culture su-
pernatants were determined using ELISA.7 Levels of IL-5, IFN-g, and
IL-10 weremeasured using Opt™ EIA sets (BD Biosciences, San Jose,
CA, USA), according to the manufacturer's instructions. Levels of IL-
17A were measured using a DuoSet™ ELISA development kit (R&D
Systems). Levels of IL-13 were measured using paired capture and
detection antibodies (BD Biosciences) and recombinant standards
(R&D Systems). The detection limit of these assays was 4 pg/ml for
IL-5, 2 pg/ml for IL-13, 8 pg/ml for IL-17A, 4 pg/ml for IFN-g, and
8 pg/ml for IL-10.
Statistical analysis
Values are given as medians. A nonparametric ManneWhitney
U test was used to compare data between groups, and Wilcoxon
signed-rank test was used to analyze data within each group. p-
values of less than 0.05 were considered to be statistically signiﬁ-
cant. Statistical analyses were performed with SPSS software
(version 11.0 SPSS, Chicago, IL, USA).
Results
Poly(IC)-induced cytokine production by DNPCs
DNPCs were stimulated with or without various concentrations
of Poly(IC) for 12 or 72 h. Either 12-h or 72-h stimulation of DNPCs
with Poly(IC) did not induce the production of IL-5 (p ¼ 0.462 and
p ¼ 0.755, respectively, at 100 mg/ml), IL-13 (p ¼ 0.236 and
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p ¼ 0.414). However, exposure to Poly (IC) for 12 h did signiﬁcantly
induce a dose-dependent increase in the production of IL-10
compared to unstimulated control cells. The maximum produc-
tion of IL-10 was detected at 100 mg/ml Poly(IC). Dose-dependent
production of IL-10 by Poly(IC) stimulation was also observed
following Poly(IC) stimulation for 72 h (Fig. 1). We therefore further
investigated the regulatory effect of Poly(IC) on DPNCs.
Effect of exposure of DPNCs to Poly(IC) on SEB-induced Th1/Th2/
Th17-related cytokine production by DNPCs
Since SEB is known to be involved in the pathogenesis of
CRSwNP, we sought to determine whether exposure of DNPCs to
Poly(IC) regulates SEB-induced cytokine production. Consistent
with our previous report, the DNPCs produced a substantial
amount of IL-5, IL-13, IFN-g and IL-17A in response to SEB.7 Pre-
exposure to Poly(IC) dose-dependently inhibited SEB-induced IL-
5, IL-13 and IL-17A production. SEB-induced IL-5, IL-13 and IL-17A
production was inhibited by 50.09% (p ¼ 0.002, Fig. 2A), 47.41%
(p ¼ 0.002, Fig. 2B) and 65.21% (p ¼ 0.002, Fig. 2D), respectively, by
pretreatment with 100 mg/ml Poly(IC) for 2 h prior to SEB stimu-
lation. Although exposure of DNPCs to Poly (IC) at a concentration
of 1 mg/ml resulted in a weak inhibition (22.98% inhibition,
p ¼ 0.041) of SEB-induced IFN-g production, exposure to 10 or
100 mg/ml Poly(IC) did not exert a signiﬁcant effect (p > 0.05,
Fig. 2C). No signiﬁcant difference in the inhibitory effect of 100 mg/
ml Poly(IC) on the production of IL-5 (p ¼ 0.644), IL-13 (p ¼ 0.926),
IFN-g (p ¼ 0.079) and IL-17A (p ¼ 0.644) was seen between asth-
matic and non-asthmatic patients.
Involvement of IL-10 in the inhibitory effect of exposure of DNPCs to
Poly(IC) on SEB-induced cytokine production
Wenext sought to determinewhether the IL-10 that is produced
by DNPCs following their exposure to Poly(IC) can regulate the ef-
fect of Poly(IC) on SEB-induced cytokine production. As compared
with the control treatment, antibody-mediated neutralization of IL-
10 signiﬁcantly enhanced the production of SEB-induced IL-5
(p ¼ 0.012, Fig. 3A), IL-13 (p ¼ 0.012, Fig. 3B), IFN-g (p ¼ 0.036,
Fig. 3C) and IL-17A (p ¼ 0.012, Fig. 3D) by DNPCs exposed to
Poly(IC). IL-10 neutralization also signiﬁcantly enhanced SEB-
induced IL-13 (p ¼ 0.018) and IFN-g (p ¼ 0.018) production byFig. 1. Poly(IC)-induced IL-10 production by nasal polyp cells. The rectangle includes
the range from the 25th to 75th percentiles; the horizontal line indicates the median,
and the vertical line indicates the range from the 10th to 90th percentiles. p-values
were determined using the Wilcoxon signed-rank test.DNPCs that were not exposed to Poly(IC), whereas it only margin-
ally enhanced SEB-induced IL-5 (p ¼ 0.063) and IL-17A (p ¼ 0.063)
production.
Involvement of the COX pathway in the inhibitory effect of exposure
of DNPCs to Poly(IC) on SEB-induced cytokine production
Since we recently reported that exposure of DNPCs to the TLR4
agonist, LPS, inhibited SEB-induced IL-5, IL-13, IFN-g and IL-17A
production by DNPCs via the COX pathway, especially through
PGE2 production, we therefore investigated whether the inhibitory
effect of Poly(IC) on SEB-induced cytokine production is also
regulated by the COX pathway.7 In the presence of the COX inhib-
itor diclofenac, the suppressive effects of Poly(IC) pretreatment of
DNPCs on SEB-induced IL-5 (p¼ 0.657, Fig. 4A) and IL-13 (p¼ 0.790,
Fig. 4B) production was abrogated, but Poly(IC) did not induce any
signiﬁcant enhancement of SEB-induction of these cytokines in the
diclofenac-treated DNPCs. In addition, Poly(IC) pretreatment
signiﬁcantly enhanced SEB-induced IFN-g production (p ¼ 0.016,
Fig. 4C) in diclofenac-treated DNPCs. In contrast, inhibition of IL-
17A production was still observed following exposure of diclofe-
nac-treated DNPCs to Poly(IC) (p ¼ 0.005, Fig. 4D). 12 h exposure to
Poly(IC) did not induce a signiﬁcant increase in PGE2 production by
DNPCs (p¼ 0.060), rather a signiﬁcant decrease in PGE2 production
was observed after 72 h of Poly(IC) stimulation (p ¼ 0.006) (Fig. 5).
Discussion
In the present study, we investigated the regulatory effects of
Poly(IC) on Th1-, Th2- and Th17-associated cytokine production in
an ex vivo model of CRSwNP. Our results demonstrated that
exposure of DNPCs to Poly(IC) induced a substantial suppression of
SEB-induced IL-5, IL-13 and IL-17A production in a Poly(IC) dose-
dependent manner, whereas there was no signiﬁcant effects of 10
and 100 mg/ml Poly(IC) on SEB-induced IFN-g production. In addi-
tion, this Poly(IC) inhibition was signiﬁcantly decreased by the
antibody-mediated neutralization of IL-10. These results suggest
that Poly(IC)-derived IL-10 plays a substantial role in the regulatory
effect of Poly(IC) on Th2- and Th17-associated cytokine production
in CRSwNP.
Poly(IC) selectively induced IL-10, and did not induce IL-5, IL-13,
IFN-g or IL-17A production by nasal polyp cells. Although Poly(IC) is
known to induce the production of pro-inﬂammatory cytokines
and chemokines including IL-6, IL-8, GM-CSF, TARC, RANTES and
TSLP, this is the ﬁrst report to demonstrate the production of IL-10
as a result of Poly(IC) stimulation of sinonasal tissues.10e15 IL-10
produced in the respiratory tract limits inﬂammation in response
to pathogens and allergens.19,20 For example, neutralization of IL-10
signiﬁcantly increased allergen-speciﬁc IL-5 and IFN-g production
by nasal polyp cells sensitized to the allergens.20 In addition,
impaired production of IL-10 was seen in patients with allergic
rhinitis.21 These results suggest that signals through TLR3 might
suppress airway inﬂammation via induction of IL-10.
Poly(IC)-induced IL-10 production has been previously reported
in both humans and mice.22,23 IL-10 is known to be produced by a
variety of cells including cells of the innate immune system such as
macrophages, monocytes, dendritic cells, NKT cells and NK cells
and also cells of the acquired immune system such as T cells and B
cells.24 For example, mousemacrophages produce IL-10 in response
to Poly(IC) in a MyD88-independent and TRIF-dependent
manner.22 In humans, Poly(IC)-treated epidermal Langerhans cells
promote the differentiation of CD4þ T cells producing IFN-g and IL-
10.23 Although nasal polyp cells are known to produce IL-10 in
response to allergens and pathogens,20,25,26 little is known about
the localization of IL-10 expression in sinonasal tissues. IL-10 is
Fig. 2. Effects of pretreatment with Poly(IC) on SEB-induced cytokine production by DNPCs. DNPCs were treated with 0, 1, 10 or 100 mg/ml Poly(IC) 2 h prior to SEB stimulation. After
72 h of incubation with SEB, levels of IL-5 (A), IL-13 (B), IFN-g (C), and IL-17A (D) within the supernatant were determined. P-values were determined using Wilcoxon signed-rank
test.
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mucosa from patients with allergic rhinitis.27,28 Future experiments
should investigate the cell types in nasal polyps that respond to
Poly(IC) by producing IL-10.
Pre-exposure of DNPCs to Poly(IC) signiﬁcantly inhibited SEB-
induced IL-5, IL-13 and IL-17A production in a dose-dependent
manner. These cytokines are known to be involved in the patho-
genesis of CRSwNP, especially in eosinophilic inﬂammation.29e32
For example, treatment with a humanized anti-IL-5 mAb signiﬁ-
cantly decreased polyp size and blood eosinophil count in patients
with CRSwNP.31 We have previously reported that the number of
cells expressing IL-17A was signiﬁcantly and positively correlated
with the degree of eosinophilia in nasal polyps.30 Together with the
ﬁnding that pre-exposure of DNPCs to 10 and 100 mg/ml Poly(IC)
had no signiﬁcant effect on IFN-g production, which is known to
inhibit airway eosinophilia, these results suggest that signals
mediated through TLR3 can suppress eosinophilic inﬂammation in
CRSwNP.33 Eosinophilic CRS is the major endotype of CRSwNP in
the United States and Europe, and has been increasing in Asia.3,34,35
For example, there was a shift from predominantly neutrophilic to
eosinophilic CRSwNP in Thai patients from 1999 to 2011.34 A crucial
role of early exposure to microbial stimuli in the prevention of later
chronic inﬂammatory conditions is known as the “hygiene (in other
words microbial) hypothesis”.8 Since single-stranded RNA viruses
and double-stranded DNA viruses produce double-stranded RNA
during replication, which is sensed by TLR3, the present results mayreﬂect this hypothesis, and suggest that early exposure to viruses
inhibits eosinophilia-associated cytokine production in CRSwNP.8
Neutralization of IL-10 signiﬁcantly reversed the suppression of
SEB-induced IL-5, IL-13, IL-17A and IFN-g production by Poly(IC).
This effect was particularly pronounced for IL-5 and IL-17A pro-
duction since IL-10 neutralization did not signiﬁcantly enhance
SEB-induced IL-5 or IL-17A production in the absence of Poly(IC)
exposure. These results suggest that the inhibitory effect of Poly(IC)
on cytokine production by DNPCs is mediated via IL-10 production.
One of the reasons why IL-10 neutralization signiﬁcantly enhanced
SEB-induced IL-13 and IFN-g production by DNPCs that were not
exposed to Poly(IC) may be due to the ﬁnding that DNPCs sponta-
neously produce IL-10, and produce signiﬁcantly more IL-10 in
response to SEB (data prepared for submission). IL-10 suppresses
IFN-g production under various conditions.36
The reason why the effect of Poly(IC) on SEB-induced IFN-g
production was not observed even though IL-10 neutralization
signiﬁcantly enhanced the production of SEB-induced IFN-g by
DNPCs exposed to Poly(IC) is not clear. One possibility is that
Poly(IC) itself can promote IFN-g production under various condi-
tions.37,38 For example, Poly(IC)-primed human dendritic cells
promote IFN-g production by CD3þ T cells and NK cells.37 Admin-
istration of Poly(IC) increased the level of IFN-g in Dermatofagoides
farina-induced model of atopic dermatitis in NC/Nga mice.38 Thus
the inhibitory effect of IL-10 induced by Poly(IC) on SEB-induced
IFN-g production may be abrogated by IFN-g-promoting effect by
Fig. 3. Effect of IL-10 neutralization on cytokine production by DNPCs. DNPCs were pretreated with or without Poly(IC) for 2 h, then stimulated with SEB in the presence of either
anti-human IL-10 mAb or control rat IgG1. After 72 h incubation, levels of IL-5 (A), IL-13 (B), IFN-g (C), and IL-17A (D) within the supernatant were determined. p-values were
determined using the Wilcoxon signed-rank test.
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and NK cells. Future study should be performed whether IL-10
neutralization induces cytokine production especially IFN-g by
DNPCs in response to Poly(IC).
We have previously reported that pre-exposure of DNPCs to LPS,
the TLR4 agonist, also inhibits SEB-induced IL-5, IL-13, IFN-g and IL-
17A production.7 Although the effect on IFN-g production was
different, pre-exposure of DNPCs to both LPS and Poly(IC) resulted
in an inhibitory effect on IL-5, IL-13 and IL-17A production. These
results suggest that both TLR3 and TLR4 signals alleviate
eosinophilia-associated cytokine production in CRSwNP. However,
the mechanism by which LPS and Poly(IC) decrease cytokine pro-
duction, especially the production of IL-5 and IL-13 cytokines,
seems to be different. It was previously shown that pre-exposure of
DNPCs to LPS signiﬁcantly enhanced SEB-induced IL-5 and IL-13
production in the presence of diclofenac, and that addition of
PGE2 signiﬁcantly reversed this enhancement by diclofenac.7
However, treatment with diclofenac did not lead to such a
reverse by Poly(IC). Indeed, sustained production of PGE2 by DNPCs
was not detected following their exposure to Poly(IC). This ﬁnding
is in contrast to PGE2 production by DNPCs in response to exposure
to LPS in which sustained PGE2 production as well as increased
expression of COX-2 and PGE2 synthase was seen.7 These datasuggested that the inhibitory effect of LPS on IL-5 and IL-13 pro-
duction is mediated by the COX/PGE2 axis, whereas the effect of
Poly(IC) is mediated by IL-10. In addition, the dose dependency of
the inhibitory effects of LPS and Poly(IC) was different. Thus, the
inhibitory effect of LPS on SEB-induced cytokine production was
more obvious at a relatively low LPS concentration (0.2 mg/ml) as
compared with a high LPS (2 mg/ml) concentration.7 On the other
hand, the inhibitory effect of Poly(IC) increased with increasing
Poly(IC) concentration.
Poly(IC) pretreatment signiﬁcantly enhanced SEB-induced IFN-g
production and conversely inhibited IL-17A production by diclo-
fenac-treated DNPC. It is known that PGE2 suppresses IFN-g pro-
duction and conversely enhances IL-17A production under various
conditions.30,39 Thus cease of PGE2 release by diclofenac treatment
may increase IFN-g production and conversely decrease IL-17A
production.
In conclusion, we demonstrated that pre-exposure of DNPCs to
Poly(IC) dose-dependently inhibited SEB-induced Th2 and Th17-
associated cytokine production in an ex vivo model of CRSwNP.
The present study outlines amechanism for the inhibitory effects of
TLR3 signaling on eosinophilia-associated cytokine production,
which is mediated by IL-10. These observations may provide a basis
for novel therapeutic approaches targeting Poly(IC) and other
Fig. 4. Effect of COX on cytokine production by DNPCs. Diclofenac-treated DNPCs were exposed or unexposed to Poly(IC) prior to SEB stimulation. After 72 h incubation, levels of IL-
5 (A), IL-13 (B), IFN-g (C), and IL-17A (D) within the supernatant were determined. p-values were determined using the Wilcoxon signed-rank test.
Fig. 5. Release of PGE2 by DNPCs in response to Poly(IC). DNPCs were cultured with or
without 100 mg/ml Poly(IC) for 12 or 72 h, and levels of PGE2 after 72 h of incubation
were measured. p-values were determined using the Wilcoxon signed-rank test.
M. Okano et al. / Allergology International 65 (2016) 96e102 101components of microbes in the management of eosinophilic airway
diseases such as CRSwNP, allergic rhinitis, and bronchial asthma.
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